DRO

Care Access is a leading decentralized research organization (DRO) that breaks down traditional barriers in clinical research for patients, sponsors, and physicians. Its innovative model brings decentralized trials, Sites On Demand™, Virtual Principal Investigators (PIs), and Mobile Sites to previously-unreachable patient populations to expand the impact of clinical research. Supported by top pharmaceutical and biotech partners across 20 different therapeutic areas, Care Access is scaling and globalizing its new model for clinical trial delivery, where more physicians and patients can engage in life-saving research to develop new therapies faster.

"Before new medications are made available to the public, they must undergo a rigorous scientific testing process. Only the few that can continue to accumulate evidence of their safety and efficacy throughout the entire process, which starts in the laboratory and proceeds up through clinical trials with patient volunteers, are allowed to continue on the path to FDA approval. Care Access is working to make this process better, faster and more efficient."

See also: Science 37